Study Details

Back
Study ID F506-CL-0611
Study Title A Randomized, Double-Blind, Placebo-Control, Multicenter Clinical Trial evaluating the Efficacy and Safety of Tacrolimus Capsules in the Treatment of Myasthenia Gravis Patients with Inadequate Response to Glucocorticoid Therapy
Clinicaltrials.gov Identifier NCT01325571
Compound Name FK506 / tacrolimus
Medical Indication or Disease Myasthenia gravis
Study Sponsor Astellas Pharma China, Inc.
Collaborator Not Applicable
Study Start Date 30-Mar-2011
Study Completion Date 22-May-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS